Dianthus Therapeutics Announces Early GO Decision Following Interim Responder Analysis in Phase 3 CAPTIVATE Trial of Claseprubart in Chronic Inflammatory Demyelinating ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.
News-Medical.Net

Immune cells use neurotransmitters to regulate health and disease

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...
Mirage News

HKU Study: Neurotransmitters' Role in Immune Response

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, 2026, in Immunity ...

Dianthus Advances Claseprubart With Positive Phase 3 Update

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference

Annexon (NASDAQ:ANNX) highlighted progress across three programs targeting the classical complement pathway during a fireside ...
pharmaphorum

The role of the opioid pathway in schizophrenia and bipolar I disorder

Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate. These key neurotransmitters – known to regulate mood, behaviour, and bodily functions – have served as the ...